CTLA4 and neoplasm: In colorectal carcinoma, inhibitory checkpoint molecules such as PD1, Tim3 and CTLA4 are transferred from regulatory T cells to tumor cells, enhancing immune suppression (Betts et al., 2012; Shin et al., 2021).